Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
Chuanhui Xu, Zixi Yi, Ruyi Cai, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 4, pp. 102778-102778
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry
Mari Kihara, Takahiko Sugihara, Junichi Asano, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 12, pp. 3661-3673
Open Access | Times Cited: 6
The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
Alfonso Gastélum Strozzi, Diana Elsa Flores‐Alvarado, Virginia Pascual‐Ramos, et al.
Rheumatology International (2023) Vol. 43, Iss. 7, pp. 1253-1264
Open Access | Times Cited: 3
Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases
Yumeko Kawano, Xiaosong Wang, Naomi J. Patel, et al.
The Journal of Rheumatology (2023) Vol. 51, Iss. 3, pp. 305-312
Open Access | Times Cited: 3
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis
Salvatore Scarpato, Marco Sebastiani, Luca Quartuccio, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 2, pp. 149-154
Open Access | Times Cited: 8
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register
Joana Starling de Carvalho, Edgard Torres dos Reis Neto, Adriana María Kakehasi, et al.
Lupus (2022) Vol. 32, Iss. 1, pp. 42-53
Open Access | Times Cited: 5
Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system
Qi Wei, Prof Philip J. Mease, Michael Chiorean, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Clinical characteristics of moderate or severe COVID‐19 infection in patients with rheumatic diseases and analysis of risk factors leading to severe disease
Wen Wang, Xiang Sun, Ran Fan, et al.
International Journal of Rheumatic Diseases (2023) Vol. 26, Iss. 10, pp. 1951-1959
Closed Access | Times Cited: 2
Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study
Chiara Tani, Chiara Cardelli, Roberto Depascale, et al.
Journal of Translational Autoimmunity (2023) Vol. 7, pp. 100221-100221
Open Access | Times Cited: 2
COVID-19 AMONG A SAMPLE OF IRAQI PATIENTS WITH RHEUMATIC DISEASES: A MULTICENTER STUDY
Faiq I. Gorial, Ali Abdulrahman Younis, Ali Alkazzaz, et al.
Military Medical Science Letters (2021) Vol. 91, Iss. 2, pp. 89-97
Open Access | Times Cited: 6
Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases—cross-sectional study from a reference centre in Spain
Clara Udaondo, Claudia Millán-Longo, Celia Permuy, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 6, pp. 1779-1784
Open Access | Times Cited: 4
Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study
D. Freites, Leticia León, Alfredo Madrid-García, et al.
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 4
The course of COVID-19 in patients with Behçet’s disease
Ayşe Ünal Enginar, Mustafa Gündoğdu
Reumatologia/Rheumatology (2021) Vol. 59, Iss. 6, pp. 356-361
Open Access | Times Cited: 5
Immune features revealed by single‐cell RNA and single‐cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID‐19 booster vaccination
Yong Fan, Siyuan Huang, Duo Wu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 4
Closed Access
Investigation of COVID‐19 infection in patients with polymyalgia rheumatica during the predominance of the omicron variant
Xinlei Ma, Lanlan Xiao, Jinzhi Wu, et al.
Rheumatology & autoimmunity (2024) Vol. 4, Iss. 3, pp. 174-179
Open Access
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study
Leonardo Palazzo, Julius Lindblom, Emelie Kihlgren Olsson, et al.
Rheumatology International (2024) Vol. 44, Iss. 10, pp. 1923-1933
Open Access
Clinical Characteristics, Prognostic Factors, and Outcomes of COVID-19 in Autoimmune Rheumatic Disease Patients: A Retrospective Case–Control Study from Astana, Kazakhstan
Kristina Rutskaya-Moroshan, Saule Abisheva, Anilim Аbіsheva, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1377-1377
Open Access
Management and associated outcomes of COVID-19 infection among Ghanaian autoimmune rheumatic disease patients
Dzifa Dey, Bright Katso, Derrick Nyame, et al.
Ghana Medical Journal (2024) Vol. 58, Iss. 3, pp. 184-191
Open Access
Investigating The Clinical Manifestations, Severity And Outcomes Of COVID-19 Among Inpatients With Rheumatic Diseases: A Retrospective Cross-Sectional Study In Iran
Alireza Sadeghi, Ayatollahi Fazlollah, Sana Hizem, et al.
Russian Open Medical Journal (2024) Vol. 13, Iss. 3
Open Access
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study
Leonardo Santos Hoff, R Naveen, Parikshit Sen, et al.
Lara D. Veeken (2024)
Open Access
COVID-19 prophylaxis, diagnostics, and treatment in patients with rheumatic diseases. The Polish experts panel opinion
Brygida Kwiatkowska, Magdalena Krajewska–Włodarczyk, Bogdan Batko, et al.
Reumatologia/Rheumatology (2024) Vol. 62, Iss. 1, pp. 4-17
Open Access
Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study
Israa Safar Alsofyani, Basim S Samman, Salem S Alhubayshi, et al.
Cureus (2024)
Open Access
Recent advancements in traditional Chinese medicine for COVID-19 with comorbidities across various systems: a scoping review
Xiyu Shang, Yuqing Cao, Yang Guo, et al.
Infectious Diseases of Poverty (2024) Vol. 13, Iss. 1
Open Access
The Hong Kong Society of Rheumatology Consensus Recommendations for COVID-19 Vaccination in Adult Patients with Autoimmune Rheumatic Diseases
Ho So, Chi Chiu Mok, Ronald Man Lung Yip
Journal of Clinical Rheumatology and Immunology (2021) Vol. 21, Iss. 01, pp. 7-14
Open Access | Times Cited: 4
Outcomes of Filipinos with inflammatory rheumatic diseases developing COVID-19 prior to vaccinations and new variants: a historical perspective
Geraldine T. Zamora, Evelyn O. Salido, Juan Javier Lichauco, et al.
Clinical Rheumatology (2023) Vol. 42, Iss. 4, pp. 1171-1175
Open Access | Times Cited: 1
Recommendations for enhanced primary series (third dose) COVID-19 vaccination for people with rheumatic diseases: Chapter of Rheumatologists, College of Physicians, Singapore
Chuanhui Xu, Manjari Lahiri, Amelia Santosa, et al.
Singapore Medical Journal (2023)
Open Access | Times Cited: 1

Scroll to top